Monotherapy with either fibrates or statins suggested a significantly greater effect of fibrates in lowering plasma Fib concentrations .
According to these findings , mechanisms associated with fibrinogen metabolism might be responsible for the distinct effects of statins and fibrates in reducing cardiovascular endpoints
BACKGROUND Several studies suggest differences between fibrates and statins in lowering plasma fibrinogen ( Fib ) concentrations , but the evidence is not definitive .
Therefore , the aim of this meta- analysis of head-to-head r and omized trials was to compare the efficacy of statins and fibrates on plasma Fib concentrations .
Both fenofibrate and atorvastatin improve vascular reactivity in combined hyperlipidaemia (fenofibrate versus atorvastatin trial--FAT).
OBJECTIVE It has been repeatedly proven that statins improve endothelial function in isolated hypercholesterolaemia but there is far less evidence in the case of combined hyperlipidaemia . Studies assessing the effects of fibrates on endothelium have been neglected . Therefore , we conducted a trial in which the effects of fenofibrate and atorvastatin monotherapy on both endothelium-dependent vascular reactivity and biochemical parameters were compared in patients with combined hyperlipidaemia . METHODS 29 otherwise healthy males ( aged 47.4+/-7.8 years ) with combined hyperlipidaemia ( total cholesterol 7.55+/-1.20 mmol/l , triglycerides 5.41+/-4.54 mmol/l ) were included into the r and omised , single-blind , cross-over study to receive either 200 mg of micronised fenofibrate or 10 mg of atorvastatin daily -- each of the drugs for a period of 10 weeks . Analysed biochemical parameters were as follows : serum total- , LDL- and HDL-cholesterol , apolipoproteins A-I and B , triglycerides , fibrinogen , uric acid , C-reactive protein ( CRP ) , insulin , and homocysteine . Endothelial function was investigated by duplex Doppler ultrasonography at the brachial artery . Two indices of endothelial-dependent postischaemic changes were used - the recently introduced index of peak blood flow ( PBF ) representing the level of reactive hyperaemia and traditional flow-mediated dilatation ( FMD ) . RESULTS We observed a small improvement in FMD after both fenofibrate and atorvastatin ( from 2.26 % to 2.98 % and 2.87 % , respectively ; NS ) . PBF increased from 448 ml/min to 536 ml/min after fenofibrate ( P=0.04 ) and to 570 ml/min after atorvastatin ( P=0.03 ) . The effects of both fenofibrate and atorvastatin on endothelial function did not differ significantly ( P-values of 0.82 and 0.47 for FMD and PBF , respectively ) . Significant correlations ( P<0.01 ) between the changes of vascular reactivity and biochemical indices were found between FMD and CRP ( r=-0.60 ) and between both FMD and PBF , and insulinaemia ( r=-0.48 and -0.56 , respectively ) only during treatment with fenofibrate . CONCLUSIONS Both fenofibrate and atorvastatin significantly improved endothelium-dependent vascular reactivity without mutual difference . The PBF was superior to FMD for the detection of this improvement . The beneficial effect of both drugs did not correlate with the change of lipid profile during therapy . The improvement of vascular reactivity during treatment with fenofibrate ( opposed to atorvastatin ) was related to the reduction of indirect marker of chronic vessel wall inflammation and of insulin resistance . The PBF was more reproducible than FMD because of considerably lower intra-subject variability
Monotherapy with either fibrates or statins suggested a significantly greater effect of fibrates in lowering plasma Fib concentrations .
According to these findings , mechanisms associated with fibrinogen metabolism might be responsible for the distinct effects of statins and fibrates in reducing cardiovascular endpoints
BACKGROUND Several studies suggest differences between fibrates and statins in lowering plasma fibrinogen ( Fib ) concentrations , but the evidence is not definitive .
Therefore , the aim of this meta- analysis of head-to-head r and omized trials was to compare the efficacy of statins and fibrates on plasma Fib concentrations .